Abstract
Life sciences are experiencing a historical shift towards a quantitative, data-rich regime. This transition has been associated with the advent of bio-informatics: mathematicians, physicists, computer scientists and statisticians are now commonplace in the field, working on the analysis of ever larger data-sets. An open question regarding what should drive scientific progress in this new era remains: will biological insight become increasingly irrelevant in a world of hypothesis-free, unbiased data analysis? This piece offers a different perspective, pin-pointing that biological thought is more-than-ever relevant in a data-rich setting. Some of the novel highthroughput information being acquired in the field of neuro-degenerative disorders is highlighted here. As but one example of how theory and experiment can interact in this new reality, our efforts in developing an idiopathic neuro-degenerative disease hematopoietic stemcell ageing theory are described.
Keywords: Bio-informatics, biological insight, high-throughput data, data analysis, neuro-degenerative disease.
Current Drug Metabolism
Title:Biological Insight, High-Throughput Datasets and the Nature of Neuro-Degenerative Disorders
Volume: 14 Issue: 7
Author(s): André X. C. N. Valente, Paulo J. Oliveira, Svetlana F. Khaiboullina, András Palotás and Albert A. Rizvanov
Affiliation:
Keywords: Bio-informatics, biological insight, high-throughput data, data analysis, neuro-degenerative disease.
Abstract: Life sciences are experiencing a historical shift towards a quantitative, data-rich regime. This transition has been associated with the advent of bio-informatics: mathematicians, physicists, computer scientists and statisticians are now commonplace in the field, working on the analysis of ever larger data-sets. An open question regarding what should drive scientific progress in this new era remains: will biological insight become increasingly irrelevant in a world of hypothesis-free, unbiased data analysis? This piece offers a different perspective, pin-pointing that biological thought is more-than-ever relevant in a data-rich setting. Some of the novel highthroughput information being acquired in the field of neuro-degenerative disorders is highlighted here. As but one example of how theory and experiment can interact in this new reality, our efforts in developing an idiopathic neuro-degenerative disease hematopoietic stemcell ageing theory are described.
Export Options
About this article
Cite this article as:
Valente X. C. N. André, Oliveira J. Paulo, Khaiboullina F. Svetlana, Palotás András and Rizvanov A. Albert, Biological Insight, High-Throughput Datasets and the Nature of Neuro-Degenerative Disorders, Current Drug Metabolism 2013; 14 (7) . https://dx.doi.org/10.2174/13892002113149990100
DOI https://dx.doi.org/10.2174/13892002113149990100 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preventing Activation of Receptor for Advanced Glycation Endproducts in Alzheimers Disease
Current Drug Targets - CNS & Neurological Disorders Melanin Concentrating Hormone Receptor Antagonists as Antiobesity Agents: From M2 to MCHR-1
Current Topics in Medicinal Chemistry Molecule of the Month
Current Topics in Medicinal Chemistry Glucose Addiction in Cancer Therapy: Advances and Drawbacks
Current Drug Metabolism Tuning and Fine-Tuning of Synapses with Adenosine
Current Neuropharmacology Dual Inhibitors of the Blood Coagulation Enzymes
Current Medicinal Chemistry Beyond The Therapeutic Effect of rTMS in Alzheimer’s Disease: A Possible Neuroprotective Role of Hippocampal BDNF? : A Minireview
Mini-Reviews in Medicinal Chemistry Clonidine in Perioperative Medicine and Intensive Care Unit: More Than An Anti-Hypertensive Drug
Current Drug Targets Actionable Nutrigenetics for Genetically Based Diseases? A New Critical Path to P4 Medicine
Current Pharmacogenomics and Personalized Medicine Integrative Physiology of Orexins and Orexin Receptors
CNS & Neurological Disorders - Drug Targets Glucocorticoids Involvement in the Control of CNS Excitability
Recent Patents on CNS Drug Discovery (Discontinued) How Would Composite Traditional Chinese Medicine Protect the Brain – An Example of the Composite Formula “Pien Tze Huang”
Current Medicinal Chemistry Small Molecules as SIRT Modulators
Mini-Reviews in Medicinal Chemistry Optimization of Cardiac Metabolism in Diabetes Mellitus
Current Pharmaceutical Design Quantitative μPET Imaging of Cerebral Glucose Metabolism and Amyloidosis in the TASTPM Double Transgenic Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Concerns with AED Conversion: Comparison of Patient and Physician Perspectives
Current Neuropharmacology EDITORIAL [Hot Topic: The Seven Biggest Risks Posed By DSM-5]
Current Psychiatry Reviews Molecular Predictors of Drug-induced Prolongation of the QT Interval
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Tau-Focused Immunotherapy for Alzheimers Disease and Related Tauopathies
Current Alzheimer Research Drug Discovery: Methods for Identifying New Drug Targets
Drug Design Reviews - Online (Discontinued)